Kestra Medical Technologies Ltd. KMTS 深 滬
等待開盤 09-17 09:30:00 美东时间
24.08
-1.100
-4.37%
華盛通- 最 高25.3281
- 今 開25.20
- 成交量 82.50万股
- 最 低 23.86
- 昨 收 25.18
- 總市值 14.34亿
- 52周最高 29.9999
- 市盈率 靜 --
- 換手率 1.39%
- 52周最低 17.34
- 委 比 66.20%
- 總股本 5956.18万
- 歷史最高 29.9999
- 量 比 1.66
- 振 幅 5.83%
- 歷史最低 13.25
- 每 手 1
- 風險率 2.68%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kestra Medical Techs Q1 EPS $(0.75) Misses $(0.62) Estimate, Sales $30.971M Beat $29.007M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 50 percent decrease over losses of $(0.50) per share from the same period last year. The company reported quarterly sales of $30.971 mi...
09-15 04:01
Kestra Medical Techs Raises FY2027 Sales Guidance from $137.000M to $141.000M vs $137.023M Est
Kestra Medical Techs (NASDAQ:KMTS) raises FY2027 sales outlook from $137.000 million to $141.000 million vs $137.023 million estimate.
09-15 04:01
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) will release its first earnings report after the closing bell on Monday, Sept. 14. Analysts expect the Kirkland, Washington-based company to report quarterly loss of 62 cents per share, versus a loss of 36 cents per share in the year-ago period. The co...
09-11 18:01
Kestra Medical Technologies Shareholders Approve Directors and Auditor
Kestra Medical Technologies Ltd. ( ($KMTS) ) has issued an update. At Kestra Me...
09-11 05:51
美股大行评级 | 最高735美元！戴尔科技绩后获11家大行上调目标价；MongoDB绩后分歧大，9家上调；4家下调；派拓网络、GitLab、美敦力获多家大行上调目标价
今日重点评级关注：Tigress Financial：维持Liftoff Mobile"买入"评级，目标价从39美元升至41美元；奥本海默：维持SpaceX"跑赢大市"评级，目标价从250美元升至280美元
09-03 13:50
BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target
BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.
09-02 18:10
美股大行评级 | Take-Two、Csquare、Standard获多家大行首予买入评级！潜在涨幅215.32%！HC Wainwright.升Innate Pharma(IPHA)目标价至7美元
今日重点评级关注：HC Wainwright & Co.：维持Innate Pharma"买入"评级，目标价从5美元升至7美元；HC Wainwright & Co.：维持Immix Biopharma"买入"评级，目标价从20美元升至25美元
08-11 11:45
JP Morgan Initiates Coverage On Kestra Medical Techs with Overweight Rating, Announces Price Target of $30
JP Morgan analyst Robbie Marcus initiates coverage on Kestra Medical Techs (NASDAQ:KMTS) with a Overweight rating and announces Price Target of $30.
08-10 18:10
美股大行评级 | 潜在涨幅284.62%！Annexon获Needham上调目标价至25美元；多家大行上调美国银行目标价
今日重点评级关注：Needham：维持Annexon"买入"评级，目标价从11美元升至25美元；Benchmark：维持Prenetics Global"买入"评级，目标价从30美元升至40美元
07-16 18:55
BTIG Maintains Buy on Kestra Medical Techs, Raises Price Target to $32
BTIG analyst Marie Thibault maintains Kestra Medical Techs (NASDAQ:KMTS) with a Buy and raises the price target from $30 to $32.
07-15 19:08
